Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression
about
Profile of agomelatine and its potential in the treatment of generalized anxiety disorderEmerging drugs for the treatment of anxietyAgomelatine beyond borders: current evidences of its efficacy in disorders other than major depressionAgomelatine in the treatment of mild-to-moderate depression in patients with cardiovascular disease: results of the national multicenter observational study PULSEComparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin.Agomelatine: an agent against anhedonia and abulia?Pharmacokinetic evaluation of agomelatine for the treatment of generalised anxiety disorder.New insights on the antidepressant discontinuation syndrome.The use of agomelatine in OCD: effects on the motivational aspects and dysregulated circadian rhythms.Neuroendocrine Regulation of Anxiety: Beyond the Hypothalamic-Pituitary-Adrenal Axis.Characterisation of Agomelatine-Induced Increase in Liver Enzymes: Frequency and Risk Factors Determined from a Pooled Analysis of 7605 Treated Patients.Melatonin protects against diazinon-induced neurobehavioral changes in rats.Effectiveness of agomelatine on anhedonia in depressed patients: an outpatient, open-label, real-world study.The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders.
P2860
Q26864049-1F5F9397-B381-4A83-BE39-AF96036E20BDQ28083141-DF3214BC-24A9-4861-8711-F5BBE56DD395Q28651498-357F9409-6D11-45C8-A482-C14EC27CA5E0Q33610031-54CDAB46-1FBA-4902-8698-F2E5A26031A5Q34040072-100294E4-5B54-4496-BC16-B3E4C7349638Q35862776-10A707B7-EAD1-42A5-8AD8-1BA879852C0CQ38168858-883852B7-2BC5-467F-84C5-FA24C586FE6FQ38169108-7ED56AAE-B0E9-4F93-B366-6AC3F0E8D2D4Q38203356-48A5CC49-C4A0-4E8B-A480-7DA62F03599AQ38238790-FC841816-C216-497D-BDCC-D700F2A3A59FQ38366416-F52984D4-2FD2-4A77-BD00-142557878AF2Q38869219-1CDA8831-6F91-40AE-A705-F807BC1700A6Q38876395-E7FEF794-7995-4B7B-827D-35E69E7DF423Q43682769-A2BCC4ED-23AF-41EC-BC89-5DBBD7441AC8Q47371574-4C37A689-6313-4DB3-92B8-CA45CF255CE4Q47382890-390B9378-D257-44E6-99D3-6F49D6FB00AA
P2860
Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression
@ast
Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression
@en
Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression
@nl
type
label
Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression
@ast
Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression
@en
Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression
@nl
prefLabel
Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression
@ast
Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression
@en
Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression
@nl
P2860
P356
P1476
Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression
@en
P2093
Francoise Picarel-Blanchot
P2860
P304
P356
10.1002/HUP.2294
P407
P577
2013-03-01T00:00:00Z